Who Owns CNTN?

Tharimmune, Inc. — Institutional Ownership & 13F Holdings

$3.32

-0.09 (-2.49%)

Market Cap

$174.9M

Shares Outstanding

35,070,691

Institutional Holders

6

Total Inst. Value

$92K

% of Float Held

0.2%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1UBS Group AG$53K38,715
2GEODE CAPITAL MANAGEMENT, LLC$20K15,366
3BRAVE ASSET MANAGEMENT INC$14K10,000
4Tower Research Capital LLC (TRC)$4K2,880
5SBI Securities Co., Ltd.$2K1,127
6BANK OF AMERICA CORP /DE/$016

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-9K$53K

Related Stocks

Frequently Asked Questions

How many institutional investors hold CNTN?

As of Q1 2025, 6 institutional investors report holding CNTN (Tharimmune, Inc.) in their 13F filings.

What percentage of Tharimmune, Inc. is owned by institutions?

Institutional investors hold approximately 0.2% of Tharimmune, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CNTN?

The largest institutional holder of CNTN is UBS Group AG with $53K in shares.

Are institutions buying or selling CNTN?

This quarter, 2 institutions opened new positions in CNTN and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.